Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-42.80	56.68	99.10
Graham Fair Price	0.00	6.69	6.69
PEG	inf	0.00	-0.78
Price/Book	-38.33	1.98	3.22
Price/Cash Flow	-38.33	66.56	107.93
Prices/Earnings	-38.33	22.71	36.83
Price/Sales	-38.33	7.13	11.56
Price/FCF	-38.33	66.56	107.93
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.48	0.48
Operating Margin	0.00	0.08	0.08
ROA	0.00	0.02	0.02
ROE	0.02	0.02	0.00
ROIC	0.01	0.01	-2.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.39	-0.29	33.68
Dividends QOQ	-0.19	0.00	inf
EBIT QOQ	-0.56	0.00	inf
EPS QOQ	-0.48	0.00	inf
FCF QOQ	0.11	0.00	inf
Revenue QOQ	-0.03	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.51	63.51	0.00
Days Sales Outstanding (DSO)	15.98	15.98	0.00
Inventory Turnover	1.42	1.42	0.00
Debt/Capitalization	0.07	0.09	35.56
Quick Ratio	1.40	1.40	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	9.55	9.55	0.00
Cash	3.50	3.50	0.00
Capex	-0.25	-0.25	0.00
Free Cash Flow	0.28	0.28	0.00
Revenue	2.66	2.66	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.88	1.88	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.79	-3.61	24.52
Naive Interpretation	Member

06 - Financial Health · Weak

Rating